166 related articles for article (PubMed ID: 11345023)
1. A method for determination of Ukrain in blood plasma for monitoring and pharmacokinetic study.
Doroshenko YM; Hodysh YY; Uglyanitsa KN; Nefyodov LI
Drugs Exp Clin Res; 2000; 26(5-6):163-70. PubMed ID: 11345023
[TBL] [Abstract][Full Text] [Related]
2. The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 tumor after a single intravenous injection.
Doroshenko YM; Karavay AV; Hodysh YY; Uglyanitsa KN; Nowicky WM; Nefyodov LI
Drugs Exp Clin Res; 2000; 26(5-6):171-7. PubMed ID: 11345024
[TBL] [Abstract][Full Text] [Related]
3. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
[TBL] [Abstract][Full Text] [Related]
4. Preliminary pharmacokinetic studies of Ukrain in rats.
Jagiello-Wójtowicz E; Kleinrok Z; Chodkowska A; Misztal G; Jagiello G
Drugs Exp Clin Res; 1998; 24(5-6):309-11. PubMed ID: 10190093
[TBL] [Abstract][Full Text] [Related]
5. Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure.
Panzer A; Joubert AM; Eloff JN; Albrecht CF; Erasmus E; Seegers JC
Cancer Lett; 2000 Nov; 160(2):237-41. PubMed ID: 11053654
[TBL] [Abstract][Full Text] [Related]
6. Ukrain: a novel antitumor drug.
Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
[TBL] [Abstract][Full Text] [Related]
7. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
Cordes N; Plasswilm L; Bamberg M; Rodemann HP
Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
[TBL] [Abstract][Full Text] [Related]
8. Ukrain both as an anti cancer and immunoregulatory agent.
Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
[TBL] [Abstract][Full Text] [Related]
9. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of seven main alkaloids of Chelidonium majus L. by ultra-performance LC with photodiode-array detection.
Gu Y; Qian D; Duan JA; Wang Z; Guo J; Tang Y; Guo S
J Sep Sci; 2010 Apr; 33(8):1004-9. PubMed ID: 20183823
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies of breast cancer with the antitumor drug Ukrain.
Nefyodov LI; Uglyanitsa KN; Smirnov VY; Karavay AV; Brzosko W
Drugs Exp Clin Res; 2000; 26(5-6):231-7. PubMed ID: 11345030
[TBL] [Abstract][Full Text] [Related]
12. Chelidonium majus L. (Ukrain) in the treatment of cancer patients.
Lohninger A; Hamler F
Drugs Exp Clin Res; 1992; 18 Suppl():73-7. PubMed ID: 1305049
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of Chelidonium majus L. alkaloid thiophosphoric acid conjugates (Ukrain) on the phenotype of normal human lymphocytes.
Slesak B; Nowicky JW; Harłozinska A
Drugs Exp Clin Res; 1992; 18 Suppl():17-21. PubMed ID: 1305038
[TBL] [Abstract][Full Text] [Related]
14. Studies concerning the effect of Ukrain in vivo and in vitro.
Brüller W
Drugs Exp Clin Res; 1992; 18 Suppl():13-6. PubMed ID: 1305037
[TBL] [Abstract][Full Text] [Related]
15. Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report).
Steinacker J; Kroiss T; Korsh OB; Melnyk A
Drugs Exp Clin Res; 1996; 22(3-5):275-7. PubMed ID: 8899347
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas.
Nowicky JW; Staniszewski A; Zbroja-Sontag W; Slesak B; Nowicky W; Hiesmayr W
Drugs Exp Clin Res; 1991; 17(2):139-43. PubMed ID: 1713821
[TBL] [Abstract][Full Text] [Related]
17. Action of Ukrain, a cytostatic and immunomodulating drug, on effects of irradiation.
Boyko VN; Voltchek IV; Petrov AS; Bubnov VP
Drugs Exp Clin Res; 1996; 22(3-5):167-71. PubMed ID: 8899323
[TBL] [Abstract][Full Text] [Related]
18. Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells.
Gagliano N; Moscheni C; Torri C; Donetti E; Magnani I; Costa F; Nowicky W; Gioia M
Anticancer Drugs; 2007 Jul; 18(6):669-76. PubMed ID: 17762395
[TBL] [Abstract][Full Text] [Related]
19. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part II: Effect on bone mineral density of the femur.
Jabłoński M; Gorzelak M; Patyra M; Jagiełło-Wójtowicz E
Drugs Exp Clin Res; 2000; 26(5-6):327-31. PubMed ID: 11345047
[TBL] [Abstract][Full Text] [Related]
20. The influence of glucose, succinate, pH of the medium and higher temperature on the cytotoxic activity of the preparation Ukrain.
Todor IN; Kazmin SD; Susak YaM ; Zemskov SV
Drugs Exp Clin Res; 1998; 24(5-6):247-52. PubMed ID: 10190083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
